Oncology Institute (TOI) Net Margin (2021 - 2025)
Historic Net Margin for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 10.08%.
- Oncology Institute's Net Margin rose 31500.0% to 10.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.62%, marking a year-over-year increase of 44200.0%. This contributed to the annual value of 13.47% for FY2024, which is 74600.0% up from last year.
- Latest data reveals that Oncology Institute reported Net Margin of 10.08% as of Q3 2025, which was up 31500.0% from 11.68% recorded in Q2 2025.
- In the past 5 years, Oncology Institute's Net Margin ranged from a high of 34.96% in Q1 2022 and a low of 39.37% during Q1 2023
- Its 5-year average for Net Margin is 12.08%, with a median of 12.86% in 2024.
- In the last 5 years, Oncology Institute's Net Margin soared by 370100bps in 2022 and then tumbled by -743300bps in 2023.
- Quarter analysis of 5 years shows Oncology Institute's Net Margin stood at 18.99% in 2021, then rose by 19bps to 15.41% in 2022, then plummeted by -42bps to 21.86% in 2023, then skyrocketed by 51bps to 10.8% in 2024, then increased by 7bps to 10.08% in 2025.
- Its Net Margin was 10.08% in Q3 2025, compared to 11.68% in Q2 2025 and 18.76% in Q1 2025.